健康和原发性硬化性胆管炎人肝脏免疫景观的单细胞、单核和空间转录组学表征
本研究采用单细胞和单核RNA测序(47,156个细胞和23,000个细胞核)及空间转录组学(1例10x Visium和5例Nanostring GeoMx DSP样本),对10例原发性硬化性胆管炎(PSC)肝脏的细胞生态系统进行图谱构建,并与24例神经死亡供体肝脏(107,542个细胞)及空间转录组学对照、3例原发性胆汁性胆管炎(PBC)肝脏的18,240个细胞和20,202个细胞核进行比较,通过流式细胞术验证PSC特异性免疫细胞表型和功能差异。结果显示PSC肝脏中存在胆管细胞样肝细胞,被多种免疫细胞群包围,PSC相关胆管、间充质和内皮细胞群表达参与免疫细胞募集的趋化因子和细胞因子转录本,CD4+ T细胞和髓系细胞扩增并表达相应受体,组织驻留巨噬细胞数量减少且对脂多糖和干扰素-γ刺激表现出功能障碍和下调的炎症反应。结论为PSC肝脏的综合图谱揭示了晚期PSC病变中髓系细胞的耗竭样表型和慢性细胞因子表达标志。
要点
- PSC肝脏中存在被多种免疫细胞包围的胆管细胞样肝细胞。
- PSC相关胆管、间充质和内皮细胞表达免疫细胞募集相关的趋化因子和细胞因子转录本。
- 组织驻留巨噬细胞数量减少,对脂多糖和干扰素-γ刺激的炎症反应下调。
核心结论
- 呈现了PSC肝脏的综合图谱,并证明晚期PSC病变中髓系细胞的耗竭样表型和慢性细胞因子表达标志。
研究设计与样本
- 采用单细胞和单核RNA测序(47,156个细胞和23,000个细胞核)及空间转录组学(1例10x Visium和5例Nanostring GeoMx DSP样本)对10例PSC肝脏进行图谱分析。
- 与24例神经死亡供体肝脏(107,542个细胞)及空间转录组学对照、3例PBC肝脏的18,240个细胞和20,202个细胞核进行比较。
- 通过流式细胞术验证PSC特异性免疫细胞表型和功能差异。
主要发现
- 伴有实质肝硬化和显著胆管周围纤维化的PSC切除标本中含有被多种免疫细胞群包围的胆管细胞样肝细胞。
- PSC相关胆管、间充质和内皮细胞群表达参与免疫细胞募集的趋化因子和细胞因子转录本。
- PSC肝脏中扩增的CD4+ T细胞和募集的髓系细胞群表达这些趋化因子和细胞因子的相应受体,提示潜在募集。
- 组织驻留巨噬细胞数量减少,对脂多糖和干扰素-γ刺激表现出功能障碍和下调的炎症反应。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is an immune-mediated cholestatic liver disease for which there is an unmet need to understand the cellular composition of the affected liver and how it underlies disease pathogenesis. We aimed to generate a comprehensive atlas of the PSC liver using multi-omic modalities and protein-based functional validation. METHODS: We employed single-cell and single-nucleus RNA sequencing (47,156 cells and 23,000 nuclei) and spatial transcriptomics (one sample by 10x Visium and five samples with Nanostring GeoMx DSP) to profile the cellular ecosystem in 10 PSC livers. Transcriptomic profiles were compared to 24 neurologically deceased donor livers (107,542 cells) and spatial transcriptomics controls, as well as 18,240 cells and 20,202 nuclei from three PBC livers. Flow cytometry was performed to validate PSC-specific differences in immune cell phenotype and function. RESULTS: PSC explants with parenchymal cirrhosis and prominent periductal fibrosis contained a population of cholangiocyte-like hepatocytes that were surrounded by diverse immune cell populations. PSC-associated biliary, mesenchymal, and endothelial populations expressed chemokine and cytokine transcripts involved in immune cell recruitment. Additionally, expanded CD4+ T cells and recruited myeloid populations in the PSC liver expressed the corresponding receptors to these chemokines and cytokines, suggesting potential recruitment. Tissue-resident macrophages, by contrast, were reduced in number and exhibited a dysfunctional and downregulated inflammatory response to lipopolysaccharide and interferon-γ stimulation. CONCLUSIONS: We present a comprehensive atlas of the PSC liver and demonstrate an exhaustion-like phenotype of myeloid cells and markers of chronic cytokine expression in late-stage PSC lesions. This atlas expands our understanding of the cellular complexity of PSC and has potential to guide the development of novel treatments. IMPACT AND IMPLICATIONS: Primary sclerosing cholangitis (PSC) is a rare liver disease characterized by chronic inflammation and irreparable damage to the bile ducts, which eventually results in liver failure. Due to a limited understanding of the underlying pathogenesis of disease, treatment options are limited. To address this, we sequenced healthy and diseased livers to compare the activity, interactions, and localization of immune and non-immune cells. This revealed that hepatocytes lining PSC scar regions co-express cholangiocyte markers, whereas immune cells infiltrate the scar lesions. Of these cells, macrophages, which typically contribute to tissue repair, were enriched in immunoregulatory genes and demonstrated a lack of responsiveness to stimulation. These cells may be involved in maintaining hepatic inflammation and could be a target for novel therapies.
引用
- Andrews TS, Nakib D, Perciani CT, et al. Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver. J Hepatol. 2024. PMID: 38199298. doi:10.1016/j.jhep.2023.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。